Skip to main content
Event

Public Workshop on the Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers

Date:
Location:

Washington, DC
United States

Event Details

Workshop Information

In June 2022, the Federal Trade Commission and the U.S. Department of Justice, Antitrust Division, hosted a two-day virtual workshop to explore new approaches to enforcing the antitrust laws in the pharmaceutical industry. The workshop, organized by FTC and DOJ staff, Offices of State Attorneys General, and international enforcement partners, took place virtually from 9:00 a.m. to 12:00 p.m. EDT on Tuesday, June 14 and 9:00 a.m. to 11:30 a.m. on Wednesday, June 15.

The workshop was the culmination of the Multilateral Pharmaceutical Merger Task Force, formed in March 2021 by then-Acting Chairwoman Rebecca Kelly Slaughter to consider how to address the varied competitive concerns that pharmaceutical mergers and acquisitions raise. Members of the Task Force included staff from the Federal Trade Commission, Canada’s Competition Bureau, the European Commission Directorate General for Competition, the U.K.’s Competition and Markets Authority, the U.S. Department of Justice’s Antitrust Division, and Offices of State Attorneys General.

The workshop featured a keynote delivered by Commissioner Slaughter and panels organized by Task Force members. Commissioner Slaughter’s keynote started the first day of the workshop, followed by plenary sessions on market concentration in the pharmaceutical sector and merger remedies. The second day featured sessions on innovation aspects of pharmaceutical mergers and how conduct by pharmaceutical companies affects merger analysis.

The virtual workshop was open to the public and registration was not required. Health policy experts, economists, attorneys, scientists, healthcare practitioners, academics, consumers, and other interested persons were encouraged to view the live webcast. 

FTC-DOJ Workshop Summary: The Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers

Dates and Virtual Attendance

June 14, 2022
9:00 a.m.–12:00 p.m.

June 15, 2022
9:00 a.m.–11:30 a.m.

The virtual workshop was open to the public and registration was not required.

Workshop Agenda

The following resources are available on the FTC’s event web page:

document iconAgenda PDF

document iconSpeaker Biographies PDF

 

Tuesday, June 14, 2022 (all times are eastern)

The following resources are available on the FTC’s event web page:

document iconJune 14 Transcript PDF

Video iconJune 14 Video

9:00–9:15 a.m.

Welcome and Introduction

Chair Lina M. Khan, U.S. Federal Trade Commission

Assistant Attorney General Jonathan Kanter, U.S. Department of Justice, Antitrust Division

9:15–9:30 a.m.

Keynote

Rebecca Kelly Slaughter, U.S. Federal Trade Commission

9:30–10:30 a.m.

Concentration Levels in the Pharmaceutical Sector

Panelists

Patricia Danzon, The Wharton School of the University of Pennsylvania

Diana Moss, American Antitrust Institute

Rena Conti, Boston University Questrom School of Business

Moderator

Thomas DeMatteo, U.S. Department of Justice

9:15–9:30 a.m.

Break

10:45–11:45 a.m.

Broken Fixes? Remedies in Pharmaceutical Mergers

Panelists

Robin Feldman, University of California, Hastings College of the Law

Youenn Beaudouin, European Commission Directorate General for Competition

Barak Richman, Duke University School of Law

Arti Rai, Duke University School of Law

Synda Mark, U.S. Federal Trade Commission

Moderator

Malinda Lee, California Attorney General’s Office

11:45 a.m.–12:00 p.m.

Closing of Day 1

Wednesday, June 15, 2022 (all times are eastern)

The following resources are available on the FTC’s event web page:

document iconJune 15 Transcript PDF

Video iconJune 15 Video

9:00–9:05 a.m.

Welcome

Viola Chen, U.S. Federal Trade Commission

9:05–10:05 a.m.

Assessment of Innovation Aspects in Pharmaceutical Mergers

Panelists

Carmine Ornaghi, University of Southampton

Paul Csiszár, European Commission Directorate-General for Competition

Elie Yoo, U.K. Competition and Markets Authority

Camille Vardon, European Commission Directorate-General for Competition

Caroline Holland, U.S. Federal Trade Commission

Moderator

Riccardo Ferrari, U.K. Competition and Markets Authority

10:05–10:20 a.m.

Break

10:20–11:20 a.m.

Prior Bad Acts as Factors in Pharmaceutical Merger Reviews

Panelists

Gwendolyn Cooley, Wisconsin Attorney General’s Office

Michael Carrier, Rutgers Law School

Scott Hemphill, NYU School of Law

Raksha Kopparam, Washington Center for Equitable Growth

Moderator

David Lawrence, U.S. Department of Justice

11:20–11:30 p.m.

Closing of Workshop


Updated June 27, 2023
Topic
Antitrust